갑상선결절은 매우 흔한 질환으로, 그 임상적 중요성은 결절의 일부 (7-15%) 가 갑상선암이라는
사실에 근거한다. 2000 년대 들어 고해상도 초음파 기기가 임상에서 널리 쓰이게 되면서 전 …

The determination of radioiodine remnant ablation (RRA) dosage in post-operation thyroid
residual tissues resection has been largely subject of discussion, yet no concise conclusion …

Radioactive iodine (RAI) therapy for differentiated thyroid cancer has been successfully
used for more than 70 years. However, there is still plenty of controversy surrounding the …

Objective The efficacy of low-dose radioiodine therapy (RIT) for intermediate-risk or high-risk
differentiated thyroid cancer (DTC) patients is controversial. Because of the country's …

Purpose To determine whether thyroid-stimulating hormone level≥ 30 mU/L is necessary
for radioiodine (131 I) remnant ablation (RRA) in patients with differentiated thyroid cancer …

Background and Purpose This study aimed to analyze the diagnostic ability of the
combination of stimulated thyroglobulin (sTg) and antithyroglobulin antibody (TgAb) in …

Objectives To compare the ablation results, therapeutic responses and adverse reactions
between a low dose (1.1 GBq) or high dose (3.7 GBq) of 131 I in low-/intermediate-risk …

Purpose: Radioiodine (131I) thyroid remnant ablation is an important treatment of
differentiated thyroid carcinoma (DTC) and various factors affecting its efficacy have been …

Objective To develop and validate a radiomics-clinical combined model combining
preoperative CT and clinical data from patients with papillary thyroid carcinoma (PTC) to …

Radioiodine therapy (RIT) is a complementary treatment to total thyroidectomy in
differentiated thyroid cancer (DTC) patients. High levels of thyroid-stimulating hormone …